Catalyst
Slingshot members are tracking this event:
Heron (HRTX) Expects to Release Top-Line Data in Early Q1 from Phase 2 Study 203 Evaluating HTX-011 in Pain Management Following Abdominoplasty
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| HRTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 04, 2017
Occurred Source:
http://www.businesswire.com/news/home/20170104006395/en/Heron-Therapeutics-Announces-Positive-Topline-Results-Phase
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Study 203, Htx-011, Pain Management, Abdominoplasty, Tummy Tuck, Top-line
